Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Reason
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Classification
Class I
Status
Terminated
Lot
Lot # GD01090, Exp 05/2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Teva Pharmaceuticals USA Inc — Class I Recall | MedicineWatch US